Table 2 Patient surgical data. Data are number (%) or percentage of patients, unless otherwise indicated as mean (SD)^a, median (IQR)^b, or median (range)^c

Donor and intraoperative data

 Donor type

  Brain death

68.20%

70.37%

67.90%

0.967

  Cardiac death

31.80%

29.63%

32.21%

  Donor age (years)^c

59.00 (18.00–84.00)

58.00 (25.00–84.00)

60.00 (18.00–78.00)

0.89

  Length of surgery (min)^b

390.00 (303.00–1436.00)

426.00 (325.00–1455.00)

380.00 (299.00–1430.00)

0.398

  CIT (min)^b

373.00 (284.00–445.00)

400.00 (359.00–467.00)

356.00 (278.00–430.00)

0.014

  WIT (min)^b

36.00 (26.00–50.00)

35.00 (28.50–45.00)

36.00 (26.00–50.00)

0.738

  Postreperfusion syndrome

46.60%

74.07%

41.61%

0.004

Transfusion During LT

  RBC (units)^b

2.00 (0.00–4.00)

3.00 (1.00–5.00)

1.00 (0.00–3.00)

0.001

 RBC infusions

0.001

  0 units

33.50%

7.41%

38.26%

  1–6 units

57.40%

70.37%

55.03%

   > 6 units

9.09%

22.22%

6.71%

  Fresh frozen plasma

12.50%

29.63%

9.40%

0.008

  Apheresis platelets

13.64%

29.63%

10.74%

0.015

  Tranexamic acid

39.20%

62.96%

33.56%

0.007

  Crystalloids (ml)^b

2280 (1228–3424)

2200 (1275–35,072)

2280 (1238–3200)

0.608

   Albumin^b

67.43%

88.89%

63.51%

0.018

 Transfusion during and 24 h after LT

  RBC (units)

2.50 (0.00–5.00)

4.00 (2.00–7.00)

2.00 (0.00–4.00)

0.001

 RBC infusions

0.001

  0 units

26.10%

3.70%

30.20%

  1–6 units

55.70%

37.04%

95.06%

   > 6 units

18.20%

59.26%

10.74%

  Fluid therapy^a (ml)^b

5234 (4153–7184)

6550 (4860–9055)

4962 (3951–6833)

0.004